MedPath

Management of urinary incontinence in Unani system of medicine.

Phase 2
Not yet recruiting
Conditions
Other specified urinary incontinence,
Registration Number
CTRI/2020/04/024539
Lead Sponsor
Jamia Hamdard
Brief Summary

After getting ethical clearance from the ethicalcommittee of Jamia Hamdard, Diagnosed female patients of Urinary Incontinence,fulfilling the inclusion criteria will be included in the study from OPD/IPD ofMajeedia Unani Hospital, Jamia Hamdard New Delhi.

Initially, the patient will be explained about thenature of the study and informed verbal and written consent in Hindi orEnglish will be taken from the patient by the researcher. A detailed medicalhistory, obstetric history, family history as well as sociodemographic data alongwith Physical examination will be recorded in the case record form, then thepatient will be allocated to the experimental or control group by randomizationmethod. Calibration of the pocket scale machine will be obtained which will beused for the measurement of pad weight. The researcher will receive the training to perform *Riyazat-e-Juziya* from experts in the concerned field.

In the experimental group, Patients will begiven *Majun Kundur* 5 grams orallytwice a day, daily for twelve weeks. Along with medicine, the researcher willprovide the demonstration to perform *Riyazat-e-Juziya*to the patients in the IBT functional room and a countercheck of *Riyazat-e-Juziya* understanding of thepatient will be done simultaneously. Supervised *Riyazat-e-Juziya* will be done every week on follow up and for therest of the days patient will perform it daily at home for twelve weeks andadherence with daily *Riyazat-e-Juziya*will be assessed by daily performance sheet.

In the control group, Patients will be given *Majun Kundur* 5 grams orally twice a day,daily for twelve weeks. They will not perform *Riyazat-e-Juziya*.

Change in symptoms of urinary incontinencewill be assessed before and after the intervention with the help of assessmenttools in both experimental as well as in the control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • 1.Females of Age group between 40-60 years.
  • 2.Patients with a complaint of urinary leakage.
  • 3.Patients willing to participate in this study and are available at the time of data collection.
  • 4.Patients who can follow commands in Hindi or English.
  • 5.Clinically stable patients.
Exclusion Criteria
  • 1.Patients having a chronic cough, UTI, Diagnosed patients of Diabetes Mellitus.
  • 2.Patients on diuretics.
  • 3.Patients with deranged kidney, hepatic and cardiac profiles.
  • 4.Diagnosed patients of grade three Stress Urinary Incontinence.
  • 5.Patients suffering from 2nd, 3rd or 4th-degree uterine prolapse, Urogenital Malignancy or any previously done pelvic floor surgery.
  • 6.Participation in another study.
  • 7.Diagnosed patients with chronic degenerative or psychiatric disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1-hour pad testing, ICIQ-FLUTS LF (International Consultation on Incontinence Questionnaire on Female Lower Urinary Tract Symptoms long form)0 day and 84th day
Secondary Outcome Measures
NameTimeMethod
1.CBC with ESR2.LFT

Trial Locations

Locations (1)

OPD of Tahaffuzi wa Samaji Tibb (Room number 10) and IPD (female ward) of Majeedia Unani Hospital

🇮🇳

South, DELHI, India

OPD of Tahaffuzi wa Samaji Tibb (Room number 10) and IPD (female ward) of Majeedia Unani Hospital
🇮🇳South, DELHI, India
Araf Fatma
Principal investigator
7065185628
afatima.fatima@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.